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BİYO-NANOTEKNOLOJİ İÇİN ÇİFT İŞLEVLİ BİR PEPTİDİN GENETİK 
MÜHENDİSLİĞİ YÖNTEMLERİ İLE OLUŞTURULMASI VE 
ÜRETİLMESİ 
ÖZET 
Doğada bulunan organizmaların çoğunluğu proteinlerin inorganik maddelerle 
etkileşimlerinden oluşan inorganik-organik melez yapılara sahiptir. Bu melez 
sistemlerin özellikleri arasında destek dokuları ve koruyucu katmanlar oluşturmak, 
iyon ve yük transferinde görev almak, çeşitli optik, manyetik ve mekanik özellikler 
geliştirmek gibi fevkalâde işlevler vardır. Bu özellikler ve işlevler, biyoteknoloji ve 
biyo-nanoteknoloji uygulamaları için genetik mühendisliği kullanılarak değiştirilmiş 
ve geliştirilmiş yapıların tasarlanması için çok büyük esin kaynağı olmaktadır. 
İşlevsel inorganik malzemelerin kontrollü olarak oluşmalarını ve düzenlenmelerini 
sağlamak için, inorganik yapılara bağlanabilen peptitlerin biyo-bağlayıcı ve 
moleküler yapı taşları olarak kullanılma potansiyelleri vardır. Faj gösterim 
kütüphanesi ya da hücre gösterim kütüphanesi gibi tümleşik biyolojiye dayalı 
moleküler kütüphaneler inorganik yüzeylere bağlanabilen proteinlerin elde 
edilmesinde en önemli yöntemlerden birisi haline gelmektedir. Seçilen peptidler 
genetik mühendisliği yöntemleri ile daha da geliştirilip modifiye edilebilirler ve 
kontrol edilebilir işlevselliklerle moleküler araçlar olarak kullanılabilirler. Gösterim 
kütüphaneleri ile seçilen peptidler genellikle 7-14 amino asit uzunluğundaki kısa 
peptidlerdir. Bağlanma ilgisini artırmak için peptid dizilerinin ardışık tekrarları 
genetik mühendisliği yöntemleri ile oluşturulabilir. Kısa peptidlerin tekrarlı yapıları 
daha iyi bir ilgi göstererek kontrol edilebilir oluşum işlemini sağlayabilirler. Artırılan 
yüzey tanıma bölgeleri peptidin bağlanma gücünde ve/veya özgüllüğünde bir artışa 
imkan sağlayabilir.  
Bu çalışmada, çift işlevli peptidin oluşturulması için hem quartza bağlanan peptidin 
(QBP1-PPPWLPYMPPWS) hem de altına bağlanan peptidin (GBP1-
MHGKTQATSGTIQS) üçlü ardışık tekrarı kullanılmıştır. İki peptid dizisi birbirine 
10 amino asitten oluşan (GGGGSGGGGT) esnek bir bağlayıcı ile bağlanmıştır. 
Peptidin üretimi için, E. coli’ ye dayalı bir ekspresyon sistemi olan TAGZyme pQE-
2 vektör sistemi kullanılmıştır. Vektör oluşturulmuş ve çift işlevli peptid Luria 
Bertani besiyerinde eksprese edilmiştir. Üretilen proteinler İmmobilize Metal Afinite 
Kromatografi yöntemi ile saflaştırılmıştır. İki peptidin birbirine bağlanması 
sonucunda peptidlerin işlevsellikleri korunmuştur. Genetik mühendisliği ile 
geliştirilmiş in vivo yapının, inorganik malzemelerin kullanıldığı biyonanoteknoloji 
uygulamaları için yapısal olarak işlevsel ve çok yönlü bir moleküler araç olması 
beklenmektedir. Üretilen peptid, altın nanotaneciklerini silis üzerine immobilize 
ederek biyosensör uygulamalarında ve başka nanoteknoloji uygulamalarında 
kullanılabilir. 
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CONSTRUCTION AND EXPRESSION OF A BI-FUNCTIONAL PEPTIDE 
BY USING GENETIC ENGINEERING METHODS FOR                             
BIO-NANOTECHNOLOGIES 
SUMMARY 
 
Many organisms found in the nature have inorganic-organic hybrid structures due to 
the interactions of proteins with inorganic materials. These hybrid systems have 
excellent functions like providing support tissues and protective coatings, taking 
place in ion transfer, developing various optical, magnetic and mechanical properties. 
These properties and functions are inspiring for designing genetically engineered 
systems for biotechnology and bio-nanotechnology applications.   
For the controlled formation and assembly of the functional inorganic materials, 
inorganic-binding peptides have an enormous potential to be used as bio-linkers and 
molecular building block. Combinatorial biology-based molecular libraries, like 
phage display or cell surface display libraries, are increasingly becoming one of the 
major methods to obtain inorganic specific peptides. Selected peptides can be further 
engineered, modified through genetic engineering methods and synthesized to utilize 
as molecular tools with controlled functionalities. Peptides selected by the display 
libraries are generally short ones, between 7-14 amino acids. To increase binding 
affinity, tandem repeats of the sequence can be generated by genetic engineering. 
Repeated structures of short peptides may show a better affinity and provide a 
controlled assembly process. The increased surface recognition sites could result in 
an enhancement in binding strength and/or specificity of the peptide. 
In this study, three tandem repeats of both quartz-binding peptide (QBP1-
PPPWLPYMPPWS) and gold-binding peptide (GBP1-MHGKTQATSGTIQS) was 
used to develop the bi-functional construct. Two peptide sequences were linked by a 
flexible linker, composed of 10 amino acids (GGGGSGGGGT). For the expression 
of the peptide, an E. coli-based expression system TAGZyme pQE-2 is used. The 
vector was constructed and the bi-functional peptide was expressed in LB medium. 
Expressed proteins were purified by using Immobilized Metal Affinity 
Chromatography. Both functionalities of the peptide are conserved after linking two 
well-characterized peptides. The genetically engineered in vivo construct is expected 
to be a structurally functional and a versatile molecular tool for bionanotechnology 
applications with inorganic materials. The peptide can be used to immobilize gold 
nanoparticles on silica for biosensor applications and for other nanotechnologies 
applications. 
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1. INTRODUCTION 
1.1. Recombinant Fusion Proteins 
Proteins are a diverse class of biomolecules important for all the cells due their 
feature to participate nearly all of the essential processes. This is why they are plenty 
in the cells. Enzymes serve as the proper molecular surface supplier and promoters 
for the chemical reactions to take place in the cells. Pumps and channels pumps 
formed by the proteins enclosed in the plasma membrane are important in the control 
of transfer into and out of the cell. Some of the proteins are important in signal 
transduction mechanisms and some of them take place in structural activities. Some 
proteins are important for immune response and protect cells from extreme 
environmental conditions or outer effects. Some are essential in stabilizing DNA 
molecules and some take place in defense mechanisms. All these variable properties 
of proteins rely on the fact that they are highly specific and selective towards their 
ligands [1, 2]. 
The functional properties of proteins are defined by the three-dimensional 
conformations they possess. Proteins have a very important feature that is they 
spontaneously fold into very well-determined and elaborate three-dimensional 
structures, which are inspired by the amino acid residues they are composed of. This 
self-folding ability of proteins composes the passage from one-dimensional sequence 
information to three dimensional biological functions. This is why proteins are so 
predominant in the world of biochemistry [2]. 
The fusion protein technology has become a very important tool in several areas of 
biochemical research studies [3]. Fusion proteins are constructed by end-to-end 
fusions of whole genes that encode the whole functional proteins and can also be 
named as hybrid proteins [4]. The construction of recombinant fusion proteins has 
been used to increase the expression of soluble proteins, to facilitate the purification 
[3, 4, 5] and immobilization [6] of the proteins. They are practical in the display of 
proteins on the surfaces of cells and phage, cellular localization (e.g. targeted 
delivery of toxic activities to disease-causing cells), metabolic engineering, in the 
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study of protein folding and protein–protein interactions in such systems as the yeast 
two-hybrid system [4]. Also its applications in biotechnology area include the 
immunoassays using hybrid molecules composed of antibody fragments or antibody 
binding domains, enzymes or green fluorescent proteins, the selection and production 
of antibodies and the engineering of bi-functional enzymes [3]. For example, insulin 
was fused with β-galactosidase for better expression. A streptavidin tag, a 
polyarginine tag, a His6tag and other small affinity tags have been used to facilitate 
purification. Thioredoxin is used as solubility tag to overcome the problems of 
insolubility [5] 
One of the most widely used applications of recombinant fusion proteins is in the 
field of protein expression and purification. The principle of this application is 
simple; the gene that encodes the protein of interest is linked to a sequence that codes 
for a protein or peptide which binds to a specific ligand. These peptides can be 
simple short sequences like poly(histidine) or whole proteins like glutathione S-
transferase or the maltose binding protein. Many of these expression and purification 
systems are commercially available [6, 7, 8]  
1.1.1 Bi-functional Recombinant Proteins 
Construction of recombinant proteins, especially multifunctional fusions, has a great 
potential in biotechnology. The idea of making a hybrid protein can be utilized in the 
production systems showing bi-functionality, especially in enzyme technology [9]. In 
molecular biology and biotechnology, enzymes having two or more combined 
activities with suitable stability, have found extensive application areas [10]. The 
natural diversity of the enzymes provide some of them to have bi-functional activity 
but most of the fusion enzymes have been done by the in vitro fusion of individual 
enzymes according to their evolutionary qualities and well-defined structures [11]. 
Artificial fusion enzymes generated by end-to-end fusion or by joining whole genes 
of intact functional proteins with a linker have been described to show bi-
functionality [10].  
The fusion of structural genes encoding enzymes catalyzing sequential reactions is 
advantageous. This will provide simple expression of a single recombinant unit 
containing multiple genes and one step purification of recombinant proteins. Physical 
proximity of the enzymes due to their genetic fusion might guide to increased rates 
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of sequential enzyme reactions. This can be supplied by directly transfer of reaction 
intermediates to the active sites of the next enzymes and avoiding the diffusion of the 
intermediates [9]. 
If the fusion proteins are to be used to assemble organized molecular layers, a 
detailed knowledge of the kinetics and thermodynamics of binding mechanism is 
essential [7]. 
1.2. Linker Regions in Fusion Proteins 
The construction of a functional fusion protein generally needs a linker region that 
provides an extended conformation to permit maximum stability of the proteins or 
the domains of proteins. The choice of the peptide linker sequence is especially 
important for retaining the functionalities of the fused proteins [3, 12]. The proper 
amino acid composition and the general folding of the linker should be considered 
[12]. Several studies about the choice of the linker regions suggest mainly that the 
flexibility and hydrophilicity of the linker region are important not to interfere with 
the functions of the domains by disturbing them. Spatial separation of the functional 
domains of a fusion protein by the appropriate linker region is effective on the 
independent working of the bi-functional domains [3]. The linker sequences with a 
higher tendency to interfere with domain folding [14] or to form α-helical or β-strand 
structures [12] are not favorable due to their effect by limiting the flexibility of the 
fusion protein and, therefore, affecting the functionality. Hence, such secondary 
structural elements should be avoided while designing a linker region [12]. Linker 
design becomes more important if a multi-domain protein is designed de novo. The 
control of the distance and the direction of the functional domains are significant to 
maximize the functions of interest [3, 13]. 
1.2.1. Amino Acids and Their Properties 
The amino acid composition of the linker sequences is the most important criterion in 
the linker design and selection. For the design of flexible linker, glycine and serine 
amino acids are widely used to minimize the steric hindrance and to provide enough 
space for the components of the fusion protein to remain their native conformation 
[6, 15 16]. The rationale of using serine and glycine-rich sequences or similar 
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sequences as linker peptides in immunological applications depend on the 
understanding that they are very flexible, show no rigid structure, and thus induces 
insignificant immune response in vivo. These linker peptides consisting of only 
glycine and serine amino acids have been utilized in the construction of several 
fusion proteins for therapeutic applications. For example, interleukin-2 is linked to 
the Fc of IgG by GGGSGGG linker sequence for expanding its short half-life and 
overcoming systemic toxicity, extracellular domain of interleukin-13 receptor is 
linked to the Fc of IgG by GSG linker sequence for treating antibody-mediated 
immune disorders. Some other studies have also signified that similar linker peptides 
consisting of repeating units of GGGGS are often used for preparing VH–VL linked 
single-chain antibodies for therapeutic applications and in vivo imaging [17]. A 
flexible peptide linker composed of (Gly4Ser)3 was used to link the variable regions 
of the heavy chain and the light chain of a recombinant antibody single-chain Fv [14] 
and to link two copies of epitopes to increase the immunoreactivity of the fusion 
peptide by increasing the distance between the two epitopes [18]. Studies on these 
diverse constructs have abundantly verified that the linker peptides with glycine and 
serine residues preserve functional properties of the fused proteins and show no 
immunogenecity in vivo [17]. Amino acids with cyclic structures, like Proline, lead 
to rigid linker sequences and provide a longer distance between the functional 
domains of the proteins [19]. 
1.3. Inorganic Binding Peptides and Genetically Engineered Polypeptides for 
Inorganics 
Until today, a little number of proteins has been discovered to bind inorganic 
materials. One of the most well-known examples of these proteins is ice-binding 
protein, which is found in several fish species, plants and insects [20].  
An inorganic binding peptide (IBP) is a sequence of amino acids which bind to an 
inorganic surface specifically and selectively. This surface might be a well defined 
one, like a single crystal or nanostructure, or a non-descriptive rough one, like a 
powder. These materials can be synthesized under physiological conditions and in 
aqueous environments that make them biocompatible. Also, they show quite stable 
surface structures and compositions. Many studies are done by using peptides that 
bind to inorganic surfaces. These surfaces could be noble metals as well as oxide 
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semiconductors [21, 22]. The specificity of a protein for a surface may rise from 
structural recognition mechanisms, like morphology and size, and chemical 
mechanisms, such as hydrogen bonding, polarity and charge effects [21]. 
Gold-binding proteins (GBPs) were the first examples of proteins generated via E. 
coli cell surface display method. In one of the studies, it was determined that gold-
binding sequences isolated by cell surface display could be taken from an 
extracellular loop of maltoporin to the N-terminus of alkaline phosphatase by 
retaining their gold-binding activity. This could propose that this activity is portable 
and independent of the environmental protein framework. [21, 23]. 
1. 3. 1. Obtaining Inorganic Binding Peptides  
There are several methods in order to acquire surface-specific proteins. The 
traditional one of these methods is extraction from hard tissues, which include 
protein isolation, purification, amino acid analysis and sequencing. Another method 
is to use proteins whose ability to bind to inorganic surfaces is previously known. 
Many of the proteins bind to inorganic surfaces non-specifically, usually by chemi-
sorption. So, their use is limited and mostly depends on chemical properties of the 
solution. An effective approach to get surface-specific proteins would be designing 
molecular design of recombinant proteins by using genetic engineering. If the surface 
topology of the wanted inorganic crystal structure can be predicted, then a molecule 
that is complementary to this surface and can be designed and this molecule could fit 
tightly to that structure with a high binding energy. These kinds of designs can be 
obtained by site-directed mutagenesis of existing proteins, by DNA shuffling or de 
novo selection polypeptide motifs by using phage or cell surface display libraries. 
[24, 25] 
The utilization of combinatorial biology techniques is a rising era for obtaining of 
inorganic binding peptides [26]. In this approach, combinatorial biology libraries are 
used for selection of inorganic-binding proteins towards specific inorganic substrate 
[21, 26, 27]. These huge libraries are made-up of random peptides having the same 
number of amino acids but different in sequence compositions. “Phage Display” and 
“Cell Surface Display” are well-known in vivo combinatorial biology techniques [28, 
29]. The libraries used for in vivo techniques are generally smaller (107-10) compared 
to the libraries used for in vitro techniques (1015), like mRNA display and ribosome 
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display [21, 27, 30] These display technologies are primarily utilized for the 
characterization of receptor binding sites, epitope mapping, the study of protein-
ligand interactions, the isolation and evolution of proteins or enzymes having 
improved or altered binding characteristics for their ligands for designing new drugs, 
enzymes, antibodies, DNA-binding proteins and diagnostic agents [31], and also 
adapted for the selection of inorganic binding peptides [21, 27]. Until now, phage 
display has been used in many researches to for the selection of peptides that are 
specific to gallium arsenide [32], silica [33], silver [34], zinc sulfide [35], calcite 
[36], cadmium sulfide [37], and noble metals such as platinum and palladium [38]. 
Cell surface display also has been applied to identify the iron oxide [27, 39], gold 
[23, 27], zinc oxide, zeolites and cuprous oxide [40] specific binders.  
The effectiveness of the display technologies come from the reality that they do not 
require a previous knowledge of the desired amino acid sequence because they can 
simply be selected and enhanced if a large enough population of random sequences is 
available. [21, 27] 
Phage display is an effective method used for selection and engineering of 
polypeptides with wanted binding specificities. The method depends on the reality 
that if gene fragments coding for polypeptides are fused to M13 coat protein genes, 
these fusion genes can be incorporated in bacteriophage particles and so, these 
heterologous proteins can be displayed on their surfaces. In this way, a physical 
bridge is formed between phenotype and genotype [41, 42]. 
The first libraries were constructed by inserting a synthetic fragment of DNA into a 
cloning site engineered into the 5`-end of gene III of an M13 filamentous 
bacteriophage. Gene III codes for pIII at 5 copies. So, using 5` pIII cloning site 
allows displaying the random peptide at the same amount of copies on the phage. 
Some types of the libraries are constrained pIII display libraries, pVIII display 
libraries, phagemid libraries, C-terminal libraries, modified libraries and scaffolded 
libraries. Constrained or cyclic libraries, encode the random polypeptide between 
two cysteine residues. The logical reason behind the cyclic library is to constrain the 
peptide and so it assumes fewer conformations. So, if a good binder is included in the 
library, the peptide will be in the accurate conformation for binding rather frequently 
than a loose linear one. [43] Other display systems are bacteriophage λ, T7 or T4 
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phage-based display systems but they are not widely used as compared to M13 phage 
display systems [21, 27]. 
Similar to phage display, cell surface display depends on the use of chimeric 
proteins, which is composed of the target sequence fused within (or to) a protein that 
is naturally located on the surface of the cell to perform display. The DNA sequence 
of the target region can be randomized to create a library of cells by using molecular 
biology techniques and each of these sequences will synthesize a different version of 
the chimeric protein on its surface. By incubating this library with a substrate or 
ligand, then washing to remove weak binders or non-binders, and reiterating the 
procedure to enhance for strong binders, a division can be selected from the original 
library that will show the capability to strongly interact with the desired ligand or 
substrate. This process is named as biopanning. Later on, amino acid compositions of 
the selected sequences can be identified by DNA sequencing due to the fact that the 
chimeric product is encoded within the plasmid of the cell [21, 27]. 
1. 3. 2. Further Design and Tailoring of Inorganic Binding Peptides 
Once the inorganic binding peptides are selected via phage or cell surface display 
technologies and characterized in terms of their binding affinities, they can be further 
engineered, modified or redesigned with improved affinities and specificities [44]. 
To increase binding affinity, tandem repeats of the sequence can be generated by 
genetic engineering [23]. Repeated structures of short peptides may show a better 
affinity and provide a controlled assembly process. The increased surface recognition 
sites could result in an enhancement in binding strength and/or specificity of the 
peptide [22, 23]. 
One of the initial assembly studies was focused on the gold-binding peptide (GBP1), 
which contains 14 amino acids (MHGKTQATSGTIQS). To increase the binding 
activity, tandem repeats of the sequence were produced by using genetic engineering 
techniques and it was observed that at least three repeats of the sequence were 
needed for a binding with higher affinity [21, 22, 23]. 
Due to their practical applications in biotechnology and materials sciences, the 
exploration of inorganic binding peptides is increasing. This acceleration leads to 
research for gaining information about the relationships between the peptide 
sequences and their binding affinities or specificities. By succeeding this, it will be 
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possible to design novel peptides with selected properties of interest in engineering 
and medicine applications. This can be called as “knowledge-based” approach to 
design these inorganic binding sequences with predictable affinities and specificities. 
The hypothesis of “knowledge-based” approach is simple when we consider the 
evolutionarily-related proteins and conserved sequences: “A set of peptides 
generated by directed evolution through in vivo selection to recognize a given solid 
material will have similar sequences, much as evolutionarily related proteins do”. 
According to this hypothesis, a bioinformatics approach is generated for the 
classification of the in vivo-selected peptides depending on their inorganic-binding 
properties. The first step of this approach is all-against-all comparisons of 
experimentally selected peptides with short amino acid sequences, which are 
categorized for their binding affinity. These comparisons will lead to scoring the 
alignments by using sequence similarity scoring matrices. Later on, brand new 
scoring matrices are developed for the optimization of the similarities within the 
strong-binder sequences and the differences between the strong- and weak-binder 
sequences. By utilizing these scoring matrices, classification of a given peptide 
sequence can be performed based on its sequence similarity to a set of 
experimentally-selected peptides. So, by combining experimental knowledge with 
bioinformatics analysis it is enabling to design peptides in a directed manner. [45] 
1.4. Bi-functional GEPIs  
An inorganic peptide that is selected combinatorially and then tailored by genetic 
engineering tools are called as genetically engineered polypeptides for inorganics 
(GEPIs). At this point, the functional linking properties of GEPI could be used either 
alone or as part of another macromolecule, like an enzyme or DNA by means of 
genetic fusion. On the other hand, a multifunctional hybrid polymeric structure could 
be developed by chemical fusion of GEPI to a synthetic polymer. These usages of 
GEPI are the heart of applications in biological materials science and engineering by 
offering addressable molecular binder, linker or self-assembler of inorganic 
structures. Just the once inorganic binding domains are identified, they can be linked 
genetically to obtain bi-functional units including two GEPI constructs to link two 
different materials to assemble complex nanocomposites and hybrid materials. Due 
to their specificity, selectivity and self-assembly properties, genetically engineered 
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protein in these hybrid structures would not only supply the vital molecular linkage 
among the inorganic substrates but also be a central element of the whole structure 
by supplying functional stability to the hybrid structure [44]. 
1.4.1 Metal and Metal Oxide Binding Property  
Thiol and silane linkages are two major molecular linkers for noble metal and metal 
oxide surfaces respectively. These two linkages are mostly non-specific and have 
been widely used in the formation of self-assembled molecules on solid substrates. 
Self-assembled GEPI monolayers could suggest new ways for designing and 
engineering novel surfaces for a wide variety of applications [21, 27] 
To accomplish nanoscale effects like quantum conduction and photonic signal 
enhancement, inorganic nanoparticles are required to be immobilized at specific 
positions on selected substrates in controlled two dimensional or three dimensional 
geometries. One of the traditional approaches to manufacture quantum dots for 
producing quantum electronic properties is to use molecular beam epitaxy. In this 
approach, quantum dots (QDs) are formed at thin film strain centers on 
semiconductor substrates. These traditional approaches are accomplished under 
stringent conditions of high temperature, ultra high vacuum and toxic environment. 
Alternatively, bi-functional GEPIs can be utilized to assembly one nano-inorganic 
particle onto another inorganic surface and to decorate the surface by homogenously 
distributed nanoparticles. This proposes that linking two GEPIs could be useful in the 
fabrication of tailored nanostructures. The recognition activity of the protein would 
give the capability to control the particle distribution and solution conditions would 
permit the control of the particle size [44]. 
It is crucial to keep two different nanoparticles together in solution with a distance by 
using one molecule. When considered the distance of these nanoparticles, by 
controlling this distance it is also possible to control the energy transfer between 
these two nanoparticles. When these two nanoparticles become close or distant to 
each other, the difference in the radiation, increase or decrease, can be utilized in 
sensing application. Another application could be the monolayer formation of a 
nanoparticle on another nanoparticle by linking two different inorganic materials.  
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1.4.2. Two important examples of IBPs; GBP1 & QBP1 
Gold-binding proteins (GBPs) were the first examples of proteins generated via E. 
coli cell surface display method. GBP1 (MHGKTQATSGTIQS) is a 14-mer peptide 
selected from a peptide library expressed on the outer surface of Escherichia coli. In 
these studies, it was determined that gold-binding sequences isolated by cell surface 
display could be taken from an extracellular loop of maltoporin to the N-terminus of 
alkaline phosphatase by retaining their gold-binding activity (Figure 1.1). This could 
propose that this activity is portable and independent of the environmental protein 
framework. Despite the higher affinity of many proteins to gold (Au) at low salt 
concentrations, it was surprising that these gold binder sequences were selected at 
high salt concentrations, which is known to inhibit and prevent binding of proteins to 
gold [21, 23]. For the increased binding activity of the peptide, tandem repeats of the 
sequence were produced by using genetic engineering techniques and it was 
observed that at least three repeats of the sequence were needed for a binding with 
higher affinity [21, 22, 23], In other studies, different repeating units of GBP1 was 
constructed through the post-selection engineering and by using the seven-repeat 
binder (7R-GBP1) efficient immobilization of gold nanoparticle was achieved [44]. 
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Figure 1.1: A gold-binding protein (3-repeat GBP1) on Au(111) and Au(112) 
surfaces. Viewed from above (a and c) and edge-on (b and d), respectively. The 
coloring corresponds to residue type: polar residues are highlighted in green, charged 
in blue, and hydrophobic in white [21] 
The Quartz-binding proteins (QBPs) are 12-mer peptides, which were first selected 
using phage display combinatorial peptide library, and then characterized to classify 
them according to their inorganic affinity. After this classification, the sequence 
similarity characteristics of the strongly-binding peptides were used and a set of de 
novo designed quartz binders were generated. Finally, these de novo peptides 
allowed in silico selection of strong-binding QBPs as the candidate of construct 
formation [44, 45]. Therefore, these QBP sequences are designed peptides in a 
directed mode by combining experimental knowledge with bioinformatics analysis 
[45]. 
1.5. Histidine-Tagged Expression Systems 
The expression and purification of recombinant proteins are important in molecular 
biology studies, especially in the characterization studies of the proteins. Despite the 
development and usage of several heterologous expression systems for the 
production of recombinant proteins, their purification can still be difficult. Besides 
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the classical purification methods, these proteins can be purified as fusion proteins by 
adding specific and small affinity tags to their sequence by recombinant DNA 
technology (Table 1.1). These affinity tags make the purification of the recombinant 
fusion proteins easier by applying affinity chromatography methods [46]. The usage 
of these affinity tags for the purification of recombinant proteins and native protein 
complexes have turned out to be highly accepted systems for many reasons. First of 
all, their efficiency and yield is much higher when purification from crude extracts 
without prior steps for removing nucleic acids or other cellular debris is considered. 
Following, they are useful for the purification of individual proteins and particularly 
protein complexes due to their mild elution conditions. Significantly, they permit the 
purification of miscellaneous proteins with comprehensive protocols when in 
comparison with conventional chromatographic tools [47]. 
Table 1.1: Affinity and solubility tags for recombinant proteins [48] 
 
Attachment of an oligo-histidine tag (also called as His-tag or 6xHistag) to a 
terminus, either N- or C- terminus, of the target protein is an excellent instance of 
very first and successful protein engineering application in order to develop a unique 
and comprehensive purification system [49].  
These systems depend on the significant selectivity and affinity of the nickel-
nitrilotriacetic acid (Ni-NTA) metal-affinity chromatography matrices, which are 
chelated metal ions used as affinity ligands towards proteins which have been fused 
to 6 consecutive histidine amino acid residues (Figure 1.3) [46, 48]. One of the 
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commercially available expression systems based on the Histidine-tag is The 
QIAexpress® System of QIAGEN [46]. 
Histidine tag-based purification system has some advantages over other affinity-tag 
chromatography systems. The interaction of the 6xHis tag with Ni-NTA matrices is 
independent from the conformation of the target protein to be purified. The 6xHis tag 
is much smaller than other frequently used affinity tags and can be used in any 
expression system because it does not obstruct the function and structure of the target 
recombinant protein. The 6xHis tag is uncharged at physiological pH and does not 
obstruct secretion. Furthermore, binding, washing, and elution steps of the 
purification are highly reproducible, and do not affect the structure of the 
recombinant protein [46]. Another important point is that, the binding specificity of 
the system facilitates the purification of proteins and peptides under both native and 
denaturing conditions [48]. 
1. 5. 1. Immobilized Metal Affinity Chromatography  
Immobilized-metal affinity chromatography (IMAC) is a commonly used method for 
quick and effective purification of recombinant proteins since 1970s. It was first 
introduced by Porath and his colleagues in 1975 as a new methodology for protein 
purification based on the affinity and binding of specific amino acids to immobilized 
metal ions and named it as Metal Chelate Affinity Chromatography. Later on, the 
method was engineered by the usage of a unique matrix Nickel(II)-Nitrilotriacetic 
acid (frequently known as Ni-NTA) which selectively binds to numerous 
neighboring histidine residues [49]. 
In IMAC, the adsorption of the target protein is succeeded by the coordination 
among immobilized metal ions, which serve as affinity ligands, and electron donor 
groups of the target protein surface. Metal ions are immobilized by the coordinative 
binding to the chelating molecules, which are covalently bound to the 
chromatography matrix. Intermediate metal ions, like Ni(II), Cu(II), Zn(II) and 
Co(II) are the most frequently  used ones by coordinating nitrogen, sulfur and 
oxygen. With these metal ions, adsorption to the matrix is achieved at pH ranges 
sustaining the nitrogens of the imidazole ring in the histidine amino acids in the –
non-ptotonated form, commonly in neutral or faintly basic medium. Also, buffers 
with high ionic strength (0.1 - 1 M) are commonly used in order to reduce the 
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unspecific electrostatic interactions with the matrix. Elution is achieved either by 
protonation or by ligand exchange via competitive molecules, like ammonium salts 
or imidazole (Figure 1.2) [49]. 
 
Figure 1.2: Chemical structures of histidine and imidazole [46] 
Despite the introduction of several different chelators to be used in IMAC, 
commercially available matrices commonly use a tridentate chelator iminodiacetic 
acid (IDA), tetradentate chelators nitrilotriacetic acid (NTA) and carboxymethylated 
aspartate (CM-Asp). Here, the terms of tridentate or tetradentate implies the number 
of occupied coordination bonds between the metal ion and the chelating agent [49]. 
Tetradentate chelating agents bind to the metal ions more firmly and less leakage 
occurs, however, tridentate chelating agents show higher binding affinities towards 
the target proteins but cannot bind tightly to metal ions, leading to low yields, 
impurity and metal-ion contamination of isolated target proteins (Figure 1.3)         
[46, 49]. 
 
Figure 1.3: Comparison of the interactions of different metal chelate matrices with 
nickel ions [46] 
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1. 5. 2. TAGZyme pQE-2 Vector  
TAGZyme pQE-2 vector is designed for the expression for N-terminally 
polyhistidine-tagged (6xHis-tagged) proteins in E. coli. The polyhistidine tag is 
designed to encode the sequence of Methionine-Lysine-Histidine6 (MKH6), that 
means a short Histidine tag and the N-tetrminus motif composed of Methionine-
Lysine brings a high level of protein expression and the lowest level of methionine 
processing in E. coli [50].  
pQE-2 vector is a low-copy plasmid and based on the T5 promoter transcription-
translation system. It contains an optimized promoter-operator element consist of 
phage T5 promoter, which is recognized by the E. coli RNA polymerase. It also 
contains two lac operator sequences which increases lac repressor binding and 
guarantees efficient repression of the T5 promoter, a synthetic ribosomal binding 
site, RBSII, for high translation rates, polyhistidine-tag sequence at the N-terminus, 
multiple cloning site and translational stop codons two strong transcriptional 
terminators (t0 from phage lambda and T1 from the rrnB operon of E. coli, in order 
to prevent read-through transcription and ensure stability of the expression product, 
β-lactamase gene (bla) for resistance to ampicillin at 100 µg/ml and ColE1 origin of 
replication (Figure 1.4) [50]. 
 
Figure 1.4: pQE-2 vector with restriction maps and sequences for the cloning 
regions [50] 
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1.6. Aim of the Study: Construction of a Bi-functional Peptide by Recombinant 
Fusion of GBP1 & QBP1 with a Flexible Peptide-Linker Region 
Once the inorganic binding peptides are selected via phage or cell surface display 
technologies and characterized in terms of their binding affinities, they can be further 
engineered with improved affinities and specificities. Next, they can be utilized as 
presenting a single function or combined to express as multifunctional constructs. In 
this study, our aim is to design a bi-functional peptide with gold and quartz binding 
ability. Both of the peptides are engineered ones with respect to their binding 
affinities. Gold binding peptide (MHGKTQATSGTIQS) is selected by cell surface 
display and well characterized, and then engineered as three repeat to have a high 
specificity for gold surface. Quartz binding peptide (PPPWLPYMPPWS) is a second 
generation de novo designed peptide via bioinformatics tools based on the phage 
display selected and well characterized ones. Both of the peptides are linked in 
multiple repeat forms to each other through different flexible aminoacid sequences, 
which consist of Glycine, Serine and Threonine. Following the vector construction, 
the peptides are expressed using in vivo systems. Next after the expression, the 
peptides are purified by using Immobilized Metal Affinity Chromatography (IMAC) 
and their bi-functional activities are tested by different tools.  
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1 Bacterial Strains 
2.1.1.1 E. coli Top10 Electrocompetent Cells 
F- mcrA∆ (mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacΧ74 recA1 araD139 ∆(araleu) 
7697  galU galK rpsL (StrR) endA1 nupG strain which is supplied within pCR 2.1-
TOPO TA Cloning Kit  (Catalog # K4500-01, Invitrogen). 
2.1.1.2 E. coli Top10 Chemically Competent Cells 
F- mcrA∆ (mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacΧ74 recA1 araD139 ∆(araleu) 
7697  galU galK rpsL (StrR) endA1 nupG strain which is supplied within pCR 2.1-
TOPO TA Cloning Kit  (Catalog # K4500-01, Invitrogen). 
2.1.2. Cloning Vectors 
2.1.2.1. pDrive Cloning Vector  
pDrive cloning vector (given in Appendix A) was purchased from QIAGEN (Catalog 
# 231122) for cloning of PCR products containing the single Adenine (A) overhang 
at each end. Adenine nucleotide was added at 3’- ends of blunt-ended PCR products 
using QIAGEN A-Addition Kit (Catalog # 231994, Qiagen).  
2.1.2.2. pCR 2.1-TOPO Cloning Vector 
pCR 2.1-TOPO cloning vector (given in Appendix B) was purchased from 
Invitrogen (Catalog # K4500-01) for cloning of PCR products containing the single 
Adenine (A) overhang at each end. Adenine nucleotide was added at 3’- ends of 
blunt-ended PCR products using QIAGEN A-Addition Kit (Catalog # 231994, 
Qiagen). 
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2.1.3. Expression Vectors 
2.1.3.1. pQE-2 Expression Vector 
TAGZyme pQE-2 vector is designed for the expression for N-terminally 
polyhistidine-tagged (6xHis-tagged) proteins in E. coli. The polyhistidine tag is 
designed to encode the sequence of Methionine-Lysine-Histidine6 (MKH6) (See 
Appendix for vector map) and was purchased from QIAGEN (Catalog # 32932).  
2.1.4 Enzymes  
2.1.4.1. Restriction Enzymes  
Pst I (CTGCA↓G, NEB Inc), Eag I (C↓GGCCG, NEB Inc) and Acc65 I 
(G↓GTACC, NEB Inc) restriction endonucleases and their reaction buffers were 
purchased from New England Biolab (Catalog # R0140S, Catalog # R0505L and 
Catalog # R0599L respectively).  
2.1.4.2. Pfu DNA Polymerase   
Pfu DNA Polymerase (recombinant) is a DNA polymerase of Pyrococcus furiosus, a 
hyperthermophillic archaebacterium. The enzyme catalyzes the incorporation of 
nucleotides into duplex DNA in the 5'→3' direction in the presence of Mg2+ at 70-
80°C. Different than Taq DNA Polymerase, Pfu DNA Polymerase has 3'→5' 
exonuclease (proofreading) activity that enables the polymerase to correct nucleotide 
incorporation errors (Catalog # EP0502). 
2.1.4.3. i-Taq DNA Polymerase   
i-Taq DNA polymerase (recombinant) is DNA polymerase of Thermus aquaticus. 
The enzyme catalyzes the incorporation of nucleotides into duplex DNA in the 5'→3' 
direction in the presence of Mg2+ at optimally 72°C and was purchased from Intron 
Biotechnology (Catalog # 25021). 
2.1.4.4. Quick T4 DNA Ligase 
Quick T4 DNA ligase  enables the ligation of cohesive end or blunt end DNA 
fragments in 5 minutes at room temperature (25°C) and was purchased from New 
England Biolabs (Catalog # M2200S). 
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2.1.5. DNA Molecular Weight Markers  
DNA molecular weight standard markers (given in Appendix C) were obtained from 
MBI Fermentas.  
2.1.6. Oligonuclotides  
Oligonucleotides given below were synthesised by Alpha DNA (Genova) company.   
3RQBP1 oligo 5`-TAAGGATCAGGTACCCCTCCTCCTTGGTTGCCTTA 
TATGCCTCCTTGGTCTCCTCCTCCTTGGTTGCCTTATA
TGCCTCCTTGGTCTCCTCCTCCTTGGTTGCCTTATATG
CCTCCTTGGTCTTAATAACTGCAGACTAC-3` 
3RQBP1 F  5`-TAAGGATCAGGTACCCCTCCTC-3` 
 
3RQBP1 R   5`-GTAGTCTGCAGTTATTAAGACCAAGGA-3` 
3RGBP1L F  5’-GCGGCCGCGCAAATGCATGGAAAAACTCAGGCA-3’ 
3RGBP1L-R 5’-GGTACCTCCACCGCCGCTACCACCTCCACCGCTCT 
GGATAGTCCCGCTG -3’ 
Oligonucleotides given below were supplied by the kits purchased from the 
companies.   
M13 -40 (pDrive) 5'-GTTTTCCCAGTCACGAC-3' 
M13 -20 (pCR 2.1) 5´-GTAAAACGACGGCCAG-3´ 
M13 Rev (pCR 2.1) 5´-CAGGAAACAGCTATGAC-3´ 
Promoter (pQE-2) 5'-CCCGAAAAGTGCCACCTG-3' 
Type III/IV (pQE-2) 5'-CGGATAACAATTTCACACAG-3' 
Reverse (pQE-2) 5’- GTTCTGAGGTCATTACTGG-3’ 
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2.1.7. Bacterial Culture Media 
2.1.7.1. LB (Luria-Bertani) Medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen) 
were dissolved in distilled water up to 1 lt and the pH was adjusted to 7.0 with 10 M 
NaOH and sterilized by autoclaving for 15 min. under 2 atm at 121°C. 
2.1.7.2. LB Agar Medium 
10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g bactoagar (Acumedia) were dissolved 
in distilled water up to 1 lt and the pH was adjusted to 7.0-7.5 with 10 M NaOH and 
sterilized by autoclaving. 
2.1.7.3. SOC Medium 
SOC medium containing 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM 
KCl, 10 mM MgCl2, 10 mM MgSO4 and 20 mM glucose was supplied within pCR 
2.1-TOPO TA Cloning Kit  (Catalog # K4500-01, Invitrogen). 
2.1.7.4. 2XYT Medium 
16 g. tryptone, 10 g. yeast extract and 5 g. NaCl were dissolved in distilled water up 
to 1 lt and the pH was adjusted to 7.0 with 10 M NaOH and sterilized by autoclaving. 
2.1.8. Stock Solutions  
2.1.8.1. Ampicillin Stock Solution  
100 mg/ml ampicillin sodium salt was dissolved in deionized water, filter-sterilized 
and stored in dark at -20°C.  
2.1.8.2. Xgal/IPTG Stock Solution 
1.25 g IPTG (Sigma) and 1 g Xgal (Fermentas) were dissolved in 25 ml DMF 
(Riedel-de-Haen). The solution was stored at –20°C in the dark.  
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2.1.8.3. 1 M IPTG Stock Solution 
2.38 mg. IPTG was dissolved in 10 ml. deionized water, filter sterilized and stored at 
-20°C.   
2.1.8.4. Glycerol Stock Solution  
80 ml glycerol (Riedel-de-Haen) and 20 ml distilled water were mixed to have 80 % 
(w/v) solution. It was sterilized for 15 minutes under 1.5 atm at 121°C.  
2.1.9. Buffers  
2.1.9.1. Na-Ac Buffer 
3 M of Na-Ac (Riedel-de-Haen) was dissolved in 65 ml distilled water. pH was 
adjusted to 5.2 and distilled water was added up to 100 ml.  
2.1.9.2. 10X TBE Buffer (1000 ml)  
108 g. of Tris base, 55 g. boric acid, and 20 ml 0.5 M EDTA at pH 8.0 were 
dissolved in 1 liter deionized water, its pH was titrated to 8.3 and sterilized for 15 
min. under 1.5 atm at 121°C.  
2.1.9.3 QIAExpressionist Lysis Buffer (1000 ml) 
7.8 g. NaH2PO4.2H2O, 17.54 g. NaCl and 0.68 g. imidazole were dissolved in 1. liter 
deionized water, its pH was titrated to 8.0 by NaOH. 
 2.1.9.4 QIAExpressionist Wash Buffer (1000 ml) 
7.8 g. NaH2PO4.2H2O, 17.54 g. NaCl and 1.36 g. imidazole were dissolved in 1. liter 
deionized water, its pH was titrated to 8.0 by NaOH. 
2.1.9.5 QIAExpressionist Elution Buffer (1000 ml) 
7.8 g. NaH2PO4.2H2O, 17.54 g. NaCl and 17 g. imidazole were dissolved in 1. liter 
deionized water, its pH was titrated to 8.0 by NaOH. 
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2.1.9.6 10X TAGZyme Buffer (500 ml) 
15.6 g. NaH2PO4.2H2O and 43.83 g. NaCl were dissolved in 500 ml. deionized 
water, its pH was titrated to 6.3 by NaOH, filter sterilized with a 0.2 µm filter and 
stored  at 4°C. 
2.1.9.7 2X SDS-PAGE Sample Buffer 
0.09 M Tris-Cl pH 6.8,  20% glycerol, 2% SDS, 0.02% bromophenol blue and 0.1 M 
DTT was mixed to prepare 10 ml. of sample buffer.  
2.1.10. Lab Equipments  
Lab equipments are given in Appendix D. 
2.2. Methods 
2.2.1. Bi-functional Peptide Vector Construction 
The vector for the production of the bi-functional peptide was constructed by 
polymerase chain reactions, restriction endonuclease digestions and ligation 
reactions. For 3RQBP1; an oligonucletide and a set of primers (Forward and 
Reverse) were designed and synthesized by Alpha DNA (Genova). For 3RGBP1; a 
set of primers were designed and synthesized by Alpha DNA (Genova). At following 
subsections the protocols of the vector construction steps is given and discussed in 
detail 
2.2.1.1. Amplification of Double Stranded DNA (3RQBP1) from an 
Oligonucleotide 
QBP1 was not cloned into any vector as a multiple repeat before. The only DNA 
sequence is found in an M13 phage genome, cloned by Deniz Şahin. Concerning the 
difficulties of multimerization procedures (time consuming and expensive), an 
oligonucleotide was designed. The oligonucleotide was designed to have the three 
repeat of the QBP1 sequence, two restriction endonuclease recognition sequences 
and two stop codons at the end of the peptide sequence. A forward and a reverse 
primer was also designed for the amplification of the 3RQBP1 oligonucleotide. iTaq 
DNA Polymerase was used for the polymerase chain reaction.  
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Polymerase Chain Reaction 
Template DNA (1 µg)  2 µl 
Forward primer (10 pmole)  1 µl 
Reverse primer (10 pmole)  1 µl 
10X PCR Buffer   2 µl 
dNTP mixture (2.5 mM each) 2 µl 
Sterile distilled water   11.8 µl 
i-Taq DNA polymerase(5 U/ µl) 0.2 µl 
Total Volume    20 µl 
Reaction Conditions 
94°C   2 min. 
94°C   20 sec 
55, 58, 60 °C  10 sec         35 cycles 
72°C   30 sec 
72°C   5 min 
 Gel Extraction Procedure  
Using MinElute Gel Extraction Kit, PCR products were extracted from the agarose 
gel (Catalog # 28604,Qiagen).  
1. DNA fragment was excised from agarose gel with a clean scalpel. Gel slices were 
put into microfuge tubes and their weight was calculated.  
2. A 3-gel volume of QG buffer was added to 1 volume of gel slice. (600 µl for 100 
mg gel). When gels were excised from a %2 or more concentrated gel, a 6-gel 
volume of QG buffer was applied.  
3. Sample was incubated at 50°C for 10 min. by vortexing every 2 min.  
4. After the gel completely dissolved, the color of the mixture was checked. QG 
buffer contains a pH indicator and gives a yellow color at pH<7.5, the optimum pH 
for DNA adsorption. If the color of the mixture was not yellow, 10 µl of 3 M sodium 
acetate, pH5.0 was added.  
5. After the gel was dissolved, 1 gel volume of room temperature isoproponal was 
added and mixed by inverting the tube several times.  
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6. Sample was applied to min-elute column and centrifuged for 1 min. at 13000 rpm.  
7. Flow-trough was discarded from collection tube.  
8. 500 µl QG buffer was applied to column and centrifuged for 1 min. at 13000 rpm.  
9. Flow-trough was discarded from collection tube and centrifuged for an additional 
1 min.  
10. Spin column placed in a 1,5 ml. microfuge tube and 10 µl Elution Buffer buffer 
was applied to elute the DNA. After 1 min. incubation tube was centrifuged for 1 
min.  
11. Eluted DNA was stored at –20
o
C for further use.  
2.2.1.2. Cloning into a TA Vector 
TA cloning vectors contain a U overhang at each ends providing easy and efficient 
ligaton of PCR products with an A overhang. Unpaired A residues are added to PCR 
products during PCR reactions generated by Taq or any other non-proofreading 
polymerases. In this study, pDrive Cloning Vector was used combined with an A-
Addition procedure.  
 A-Addition Reaction  
Gel extracted PCR product   4 µl (80 ng) 
5X QIAGEN A-Addition Master Mix* 2 µl 
Sterile Distilled Water   4 µl 
Total Volume     10 µl 
* QIAGEN® A-Addition Kit from Qiagen. (Catalog # 231994, Qiagen)  
Reaction conditions  
Incubated at 37oC for 30 min.  
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 Ligation Reaction  
          Tube 1           Tube 2 
pDrive Cloning Vector (50 ng/ µl)  1  µl  1  µl 
PCR product from A Addition Reaction 1 µl  2 µl 
Sterile Distilled Water   3 µl  2 µl 
Ligation Master Mix, 2X*   5 µl  5 µl 
Total Volume     10 µl  10 µl 
* PCR Cloning Kit from Qiagen. (Catalog # 231122, Qiagen)  
Reaction conditions  
The samples were incubated for 90 min. at 16°C and 10 min. at 70°C for ligase 
inactivation. 
 Preparation of Xgal/IPTG-Amp plates  
100 µl Xgal/IPTG solution and 50 µl ampicillin solution were put into 50 ml liquid 
warm LB agar and was poured onto plastic sterile petri dishes.  
 Transformation Procedure for Plasmids  
 1. 10 µl ligation product was mixed with 40 µl E. coli Top10 
electrocompetent cells in a prechilled electroporation cuvette.  
 2. Cuvette was placed into electroporator and 1800 Volts was applied.  
 3. 250 µl 2XYT medium was added to the cuvette and whole mixture was 
transferred into a microfuge tube. The tube was incubated at 37°C, 200-250 rpm for 
45 min on an orbital shaker.  
 4. After incubation, transformation mixture was spread onto LB agar plates 
containing Xgal/IPTG-Ampicillin by using a spreader with two dilutions (100 and 
200 µl).  
 5. Plates were incubated overnight (17 h.) at 37°C.  
2.2.1.3. Plasmid DNA Purification 
Following overnight incubation, white colonies were selected and grown overnight in 
5 ml. LB liquid media containing 5 µl Ampicillin. 850 µl of this bacterial culture was 
mixed with 150 µl 80% glycerol and stored at –80oC. Plasmid DNA was purified 
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from 3 ml for sequencing and further applications by using Roche High Pure Plasmid 
Isolation Kit (Catalog # 1 754 785). Purification procedure is described in detail 
below.  
1. 3 ml of the culture is centrifuged 60 sec. at 6000 g. 
2. The supernatant is discarded. 
3. The pellet is resuspended in 250 µl Suspension Buffer + RNase. 
4. 250 µl Lysis Buffer is added, mixed gently by inverting the tube 3 to 6 times 
and incubated at 15-25 ºC for 5 min. 
5. 350 µl chilled Binding Buffer is added, mixed gently and incubated on ice  
for 5 min. 
6. The samples are centrifuged at 13.000 g. for 10 min. 
7. High Pure Filter Tubes are inserted into Collection Tubes. 
8. Supernatant is transferred to High Pure Filter Tube and centrifuged at 13.000 
g. for 1 min. 
9. The flow-through is discarded. 
10. 500 µl Wash Buffer I is added and centrifuged at 13.000 g for 1 min. 
11. The flow-through is discarded. 
12. 700 µl Wash Buffer II is added and centrifuged at 13.000 g for 1 min. 
13.  The flow-through is discarded and an additional 1 min. centrifugation at 
13.000 g. is done. 
14. The filter tube is placed in 1.5 ml microcentrifuge tube and 100 µl Elution 
Buffer is added. 
15. The samples are centrifuged at 13.000 g. for 1 min. and purified plasmid 
DNA was stored at -20°C. 
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2.2.1.4. Plasmid DNA Sequencing  
Plasmid DNA   1  µl (200 ng) 
M13 -40 Primer  3.2 µl 
5X Sequencing Buffer* 1 µl 
Big Dye Terminator*  2 µl 
Sterile Distilled Water 2.8 µl 
Total Volume   10 µl 
* Big dye® terminator v 3.1 cycle sequencing Kit from Applied Biosystems.  
Reaction conditions  
95°C 5 min. 
95°C 1 min. 
50°C 30 sec        30 cycles 
60°C 4 min. 
 NaAc-Ethanol Precipitation (Purification) of PCR Products 
1. 1 µl 3M pH 4.6 sodium acetate (cold) and 25 µl 95 % ethanol (cold) were mixed 
for each sample.  
2. 26 µl mixture was added into each PCR product and samples were incubated on 
ice for 15 min.  
3. After incubation, samples were centrifuged for 15 min. at 13000 rpm.  
4. Supernatant was discarded and DNA pellet was washed with 250 µl cold %70 
ethanol.  
5. Samples were centrifuged for 15 min. at 13000 rpm.  
6. Ethanol was discarded, the residual ethanol was evaporated by incubating at 95oC.  
7. DNA pellet was dissolved in 20 µl formamide.  
8. Samples were denatured by putting at 95oC for 3 minutes and then at -20oC for 5 
min.  
ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer was used for 
DNA sequencing.  
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2.2.1.5. Amplification of Double Stranded DNA (3RGBP1+Linker) from pSURE 
30Q Vector 
3RGBP1 was previously cloned into p53Q vector, which was successfully done by 
Sibel Çetinel. So; a forward and a reverse primer was designed to amplify this 
sequence by introducing two restriction sites and a 10 aa-length linker for linking 
two IBPs. For the amplification of the 3RGBP1+Linker, a proofreading polymerase; 
Pfu DNA Polymerase was used.  
Polymerase Chain Reaction 
Template DNA (1 µg)  2 µl 
Forward primer (10 pmole)  1 µl 
Reverse primer (10 pmole)  1 µl 
10X Pfu Buffer with MgSO4  5 µl 
dNTP mixture (2.5 mM each) 1 µl 
Sterile Distilled Water  39.5 µl 
Pfu Polymerase (2.5 U/µl)  0.5 µl 
Total Volume     50 µl 
Reaction Conditions 
95°C 3 min. 
95°C 30 sec. 
50°C 30 sec.      30 cycles  
72°C 2 min. 
72°C: 5 min. 
 Gel Extraction Procedure  
Using MinElute Gel Extraction Kit, PCR products were extracted from the agarose 
gel (Catalog # 28604,Qiagen).  
1. DNA fragment was excised from agarose gel with a clean scalpel. Gel slices were 
put into microfuge tubes and their weight was calculated.  
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2. A 3-gel volume of QG buffer was added to 1 volume of gel slice. (600 µl for 100 
mg gel). When gels were excised from a %2 or more concentrated gel, a 6-gel 
volume of QG buffer was applied.  
3. Sample was incubated at 50°C for 10 min. by vortexing every 2 min.  
4. After the gel completely dissolved, the color of the mixture was checked. QG 
buffer contains a pH indicator and gives a yellow color at pH<7.5, the optimum pH 
for DNA adsorption. If the color of the mixture was not yellow, 10 µl of 3 M sodium 
acetate, pH5.0 was added.  
5. After the gel was dissolved, 1 gel volume of room temperature isoproponal was 
added and mixed by inverting the tube several times.  
6. Sample was applied to min-elute column and centrifuged for 1 min. at 13.000 rpm.  
7. Flow-trough was discarded from collection tube.  
8. 500 µl QG buffer was applied to column and centrifuged for 1 min. at 13.000 rpm.  
9. Flow-trough was discarded from collection tube and centrifuged for an additional 
1 min.  
10. Spin column was placed in a 1,5 ml microfuge tube and 10 µl Elution Buffer was 
applied to elute the DNA. After 1 min. incubation tube was centrifuged for 1 min.  
11. Eluted DNA was stored at –20
o
C for. 
2.2.1.6. Cloning into a TA Vector 
TA cloning vectors contain a U overhang at each ends providing easy and efficient 
ligaton of PCR products with an A overhang. Unpaired A residues are added to PCR 
products during PCR reactions generated by Taq or any other non-proofreading 
polymerases. Because Pfu polymerase, which is a proofreading polymerase was used 
in amplifying 3RGBP1+Linker, an A-Addition procedure is needed. In this study, 
pCR®2.1-TOPO Cloning Vector was used. 
 A-Addition Reaction  
Gel extracted PCR product   5  µl (150 ng) 
5X QIAGEN A-Addition Master Mix* 2 µl 
Sterile Distilled Water   3 µl 
Total Volume     10 µl 
* QIAGEN® A-Addition Kit from Qiagen. (Catalog # 231994, Qiagen)  
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Reaction conditions  
Incubated at 37oC for 30 min.  
 Ligation Reaction  
TOPO Vector (10 ng/ µl)   1 µl 
PCR product from A Addition Reaction 3 µl 
Sterile Distilled Water   1 µl 
Salt Solution*     1µl 
Total Volume     6µl 
* pCR®2.1-TOPO TA Cloning Kit from Invitrogen (Catalog # K4500-01, Invitrogen) 
Reaction conditions  
The samples were incubated for 5 min. at room temperature (25°C ) and put on ice 
for transformation. 
 Preparation of Xgal/IPTG-Amp plates  
100 µl Xgal/IPTG solution and 50 µl ampicillin solution were put into 50 ml liquid 
warm LB agar and was poured onto plastic sterile petri dishes.  
 Transformation Procedure for Plasmids  
1. 1 vial of TOP10 chemically competent cells was thawed on ice. 
2. 2 µl of the TOPO® cloning reaction was added into the vial of competent 
cells, mixed gently and incubated on ice for 30 min.  
3. The cells were heat-shocked for 30 seconds at 42°C without shaking. 
4. The tubes were immediately transferred to ice. 
5. 250 µl of room temperature S.O.C. medium was added to the cells. 
6. The tube was tightly capped and shaked horizontally at 200 rpm at 37°C for 1 
hour. 
7. 4 dilutions (25, 50, 75 and 150 µl) were spread from the transformation 
reaction onto pre-warmed LB agar plates containing Xgal/IPTG-Ampicillin 
by using a spreader. 
 The plates were incubated overnight at 37°C. 
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2.2.1.7. Plasmid DNA Purification 
Following overnight incubation, white colonies were selected and grown overnight in 
5 ml. LB liquid media containing 5 µl Ampicillin. 850 µl of this bacterial culture was 
mixed with 150 µl 80% glycerol and stored at –80oC. Plasmid DNA was purified 
from 3 ml for sequencing and further applications by using Roche High Pure Plasmid 
Isolation Kit (Catalog # 1 754 785). Purification procedure is described in detail 
below. 
1. 3 ml of the culture is centrifuged 60 sec. at 6000 g. 
2. The supernatant is discarded. 
3. The pellet is resuspended in 250 µl Suspension Buffer + RNase. 
4. 250 µl Lysis Buffer is added, mixed gently by inverting the tube 3 to 6 times 
and incubated at 15-25 ºC for 5 min. 
5. 350 µl chilled Binding Buffer is added, mixed gently and incubated on ice  
for 5 min. 
6. The samples are centrifuged at 13.000 g. for 10 min. 
7. High Pure Filter Tubes are inserted into Collection Tubes. 
8. Supernatant is transferred to High Pure Filter Tube and centrifuged at 13.000 
g. for 1 min. 
9. The flow-through is discarded. 
10. 500 µl Wash Buffer I is added and centrifuged at 13.000 g for 1 min. 
11. The flow-through is discarded. 
12. 700 µl Wash Buffer II is added and centrifuged at 13.000 g for 1 min. 
13.  The flow-through is discarded and an additional 1 min. centrifugation at 
13.000 g. is done. 
14. The filter tube is placed in 1.5 ml microcentrifuge tube and 100 µl Elution 
Buffer is added. 
15. The samples are centrifuged at 13.000 g. for 1 min. and purified plasmid 
DNA was stored at -20°C. 
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2.2.1.8. Plasmid DNA Sequencing  
Plasmid DNA   1  µl (100 ng) 
M13 -20 Primer  3.2 µl 
5X Sequencing Buffer* 2 µl 
Big Dye Terminator*  2 µl 
Sterile Distilled water 1.8 µl 
Total Volume   10 µl 
* Big dye® terminator v 3.1 cycle sequencing Kit from Applied Biosystems. 
Reaction conditions  
95°C 5 min. 
95°C 1 min. 
50°C 30 sec.       30 cycles 
60°C 4 min. 
 NaAc-Ethanol Precipitation (Purification) of PCR Products 
1. 1 µl 3M pH 4.6 sodium acetate (cold) and 25 µl 95 % ethanol (cold) were mixed 
for each sample.  
2. 26 µl mixture was added into each PCR product and samples were incubated on 
ice for 15 min.  
3. After incubation, samples were centrifuged for 15 min. at 13000 rpm.  
4. Supernatant was discarded and DNA pellet was washed with 250 µl cold %70 
ethanol.  
5. Samples were centrifuged for 15 min. at 13000 rpm.  
6. Ethanol was discarded, the residual ethanol was evaporated by incubating at 95oC.  
7. DNA pellet was dissolved in 20 µl formamide.  
8. Samples were denatured by putting at 95°C for 3 min. and then at -20oC for 5 min.  
ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer was used for 
DNA sequencing.  
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2.2.1.9 Cloning of 3RQBP1 into pQE-2 Expression Vector 
During the amplification of the 3RQBP1 coding sequence, two restriction sites to 
each ends of the sequence was also introduced. These restriction sites were 
recognized by the enzymes PstI and Acc65I. pDrive plasmid vector having the 
3RQBP1 sequence and the expression vector pQE-2 were digested with these 
restriction enzymes and the DNA fragments were extracted from the gel. Cleaned 
and concentrated insert DNA was ligated into pQE-2 vector. Procedure is described 
in detail below.   
 Restriction Enzyme Digestion 
Digestion of pQE-2 
pQE-2 DNA   10  µl 
10X NEB Buffer 3  1.5 µl 
BSA    0.15 µl 
PstI (20 U/ µl)   0.75 µl 
Acc65I (10 U/ µl)  0.75 µl 
Sterile Distilled Water 1.85 µl 
Total Volume   15 µl 
Reaction conditions  
Incubated at 37°C for 7 h. and then at 80°C for 20 min. for enzyme inactivation.  
Digestion reaction was run on a 1% agarose gel and the DNA band corresponding to 
our vector DNA fragment was extracted from the gel.  
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Digestion of pDrive 
pDrive DNA   20  µl 
10X NEB Buffer 3  3 µl 
BSA    0.3 µl 
PstI (10 U/ µl)   1.5 µl 
Acc65I (10 U/ µl)  1.5 µl 
Sterile Distilled Water 3.7 µl 
Total Volume   30 µl 
Reaction conditions  
Incubated at 37°C for 7 h. and then at 80°C for 20 min. for enzyme inactivation.  
Digestion reaction was run on a 2.5% agarose gel and the DNA band corresponding 
to our desired DNA fragment was extracted from the gel. 
 Ligation into pQE-2 
Component Volume 
Insert (Digestion product) (3:1) 1  µl (5 ng) 
Digested pQE-2 Vector 1.5 µl (50 ng) 
Sterile Distilled Water 7.5 µl 
2X Quick Ligation Buffer* 10 µl 
Quick T4 DNA Ligase 1 µl 
Total Volume 21 µl 
* Quick Ligation™ Kit from New England BioLabs (Catalog # M2200S) 
 Reaction conditions  
Incubated at room temperature (25°C) for 15 min. and then chilled on ice. 
 Transformation 
1. 1 vial of TOP10 chemically competent cells was thawed on ice. 
2. 4 µl (10 ng) of the ligation reaction was added into the vial of competent cells, 
mixed gently by pipetting up and down and incubated on ice for 30 min.  
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3. The cells were heat-shocked for 1 minute at 42°C without shaking. 
4. The tubes were immediately transferred to ice and chilled for 5 min. 
5. 300 µl of room temperature S.O.C. medium was added to the cells. 
6. The tube was incubated at 200 rpm at 37°C for 1 hour. 
7. 4 dilutions (25, 50, 75 and 150 µl) were spread from the transformation reaction 
onto pre-warmed LB agar plates containing Xgal/IPTG-Ampicillin by using a 
spreader. 
8. The plates were incubated overnight at 37°C. 
2.2.1.10. Plasmid Purification 
Plasmid DNA from white colonies were purified by using Roche High Pure Plasmid 
Isolation Kit (Catalog # 1 754 785) with the procedure given in detail above (2.2.1.3) 
2.2.1.11. Sequencing of Plasmid DNA 
Purified plasmid DNA samples were sequenced by using Big dye® terminator v 3.1 
cycle sequencing Kit from Applied Biosystems with the procedure given in detail 
above (2.2.1.4). ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer 
was used for DNA sequencing. 
2.2.1.12. Cloning of 3RGBP1+Linker into pQE-2 Expression Vector 
During the amplification of the 3RGBP1 from pSB3053 vector, a linker sequence 
composed of 10 amino acids (GlyGlyGlyGlySerGlyGlyGlyGlyThr) was added to the 
C terminus of the peptide sequence. Glycine and Threonine residues at the end of the 
linker sequence were chosen as they have a nucleotide sequence of GGTACC, which 
is the same as the recognition site of the restriction enzyme Acc65I. So, the other 
restriction site recognized by EagI was also introduced during amplification. pCR 
2.1-TOPO plasmid vector having the 3RGBP1+Linker sequence and the expression 
vector pQE-2 were digested with these restriction enzymes and the DNA fragments 
were extracted from the gel. Cleaned and concentrated insert DNA was ligated into 
pQE-2 vector. Procedure is described in detail below. 
 
 
 
    
  36 
 
 Restriction Enzyme Digestion 
Digestion of pQE-2 
pQE-2 DNA (3RQBP1 inserted) 10  µl 
10X NEB Buffer 3   2 µl 
BSA     0.2 µl 
EagI (10 U/ µl)   1 µl 
Acc65I (10 U/ µl)   1 µl 
Sterile Distilled Water  5.8 µl 
Total Volume    20 µl 
Reaction conditions  
Incubated at 37°C for 7 h. and then at 65°C for 20 min. for enzyme inactivation.  
Digestion reaction was run on a 1% agarose gel and the DNA band corresponding to 
our vector DNA fragment was extracted from the gel. 
Digestion of pCR 2.1-TOPO 
pCR 2.1-TOPO DNA  10  µl 
10X NEB Buffer 3  2 µl 
BSA    0.2 µl 
PstI (10 U/ µl )  1 µl 
Acc65I (10 U/ µl)  1 µl 
Sterile Distilled Water 5.8 µl 
Total Volume   20 µl 
Reaction conditions  
Incubated at 37°C for 7 h. and then at 65°C for 20 min. for enzyme inactivation.  
Digestion reaction was run on a 2.5% agarose gel and the DNA band corresponding 
to our desired DNA fragment was extracted from the gel. 
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 Ligation into pQE-2 
Insert (Digestion product) (3:1) 0.5  µl  (12 ng) 
Digested pQE-2 Vector 1 µl (50 ng) 
Sterile Distilled Water 8.5 µl 
2X Quick Ligation Buffer* 10 µl 
Quick T4 DNA Ligase 1 µl 
Total Volume 21 µl 
* Quick Ligation™ Kit from New England BioLabs (Catalog # M2200S) 
 Reaction conditions  
Incubated at room temperature (25°C) for 15 min. and then chilled on ice. 
 Transformation 
1. 1 vial of TOP10 chemically competent cells was thawed on ice. 
2. 3 µl (7.5 ng) of the ligation reaction was added into the vial of competent cells, 
mixed gently by pipetting up and down and incubated on ice for 30 min.  
3. The cells were heat-shocked for 1 minute at 42°C without shaking. 
4. The tubes were immediately transferred to ice and chilled for 5 min. 
5. 300 µl of room temperature S.O.C. medium was added to the cells. 
6. The tube was incubated at 200 rpm at 37°C for 1 hour. 
7. 4 dilutions (25, 50, 75 and 150 µl) were spread from the transformation reaction 
onto pre-warmed LB agar plates containing Xgal/IPTG-Ampicillin by using a 
spreader. 
8. The plates were incubated overnight at 37°C. 
2.2.1.13. Plasmid Purification 
Plasmid DNA from white colonies were purified by using Roche High Pure Plasmid 
Isolation Kit (Catalog # 1 754 785) with the procedure given in detail above (2.2.1.3) 
2.2.1.14. Sequencing of Plasmid DNA 
Purified plasmid DNA samples were sequenced by using Big dye® terminator v 3.1 
cycle sequencing Kit from Applied Biosystems with the procedure given in detail 
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above (2.2.1.4). ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer 
was used for DNA sequencing. 
2.2.2. Expression and Purification of the Peptide 
Following construction of the vector for the bi-functional peptide, the expression and 
the purification of the peptide was done. For the purification process, Ni-NTA IMAC 
(Nickel-NitriloTriAsetic Acid Immobilized Metal Affinity Chromatography) was 
used.  
 Culturing in LB medium 
For overnight culture, 20 µl of cells were inoculated into 5 ml LB medium and 
incubated overnight at 37ºC on an orbital shaker at 200 rpm.. This culture was 
inoculated into a flask of 50 ml LB medium (%10 inoculation) and was incubated 
overnight at 37ºC on an orbital shaker at 200 rpm. Then the culture was inoculated 
into a flask of 1 L LB medium (%5 inoculation) and was incubated at 37ºC on an 
orbital shaker at 200 rpm until its OD600 is 0.5. Then the culture was induced by 
adding 1 ml of 1M IPTG (1 mM final concentration) and then grown at 37ºC for five 
hours. 
After incubation, the culture was centrifuged at 5000 g. for 15 minutes and the 
pellets were used for protein extraction. 
 Protein extraction 
The pellets containing the cells were used for the purification of the bi-functional 
peptide. The details of the procedure are given below; 
1. The cells were resuspended in 8 ml lysis buffer. 
2. 1 mg/ml lysozyme was added and incubated on ice for 30 minutes.  
3. The cells were sonicated on ice (Six 10 s. bursts at 100 W. with a 10 s. 
cooling period between each burst). 
4. The cells were lysed gently by vortexing. 
5. The lysate was centrifuged for 20 minutes at 10 000 g. 
6. The supernatant was transferred to a fresh tube. 
7. 500 µl of Ni-NTA resin was added to the tube and mixed for 30 minutes 
at 4ºC. 
8. The samples were centrifuged for 20 seconds at 5000 g. to pellet the resin, 
the supernatant was transferred to a fresh tube. 
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9. The resin was washed 3 times with 4 ml of wash buffer, centrifuged for 
20 seconds at 5000 g. between each washing step, the supernatant was 
removed. 
10. The protein was eluted 4 times with 500 µl elution buffer, centrifuged for 
20 seconds at 5000 g. between each elution step, the supernatant was 
transferred to a fresh tube.  
 SDS-PAGE  
Obtained samples were analyzed by using SDS-PAGE. The stacking gel (8%) and 
the separating gel (20%) were prepared according to the amounts below; 
Table 2.1: Ingredients of stacking and separating gel for SDS-PAGE 
 Stacking Gel (8%) Separating Gel (20%) 
Acrylamide-Bisacrylamide 
Mixture (30%) 
1.3 ml 6.6 ml 
Tris-HCl Buffer 1.25 ml (0.5 M, pH 6.8) 2.5ml (1.5 M, pH 8.8) 
%10 APS 50 µl 100 µl 
%10 SDS 50 µl 100 µl 
TEMED 20 µl 20 µl 
dH2O 2.33 ml 680 µl 
Total Volume 5 ml 10 ml 
 
10 µl of each sample was mixed with 10 µl of 2X SDS Sample Application 
Buffer and loaded into the wells of the gel. The samples were run at 125 V for 3 
hours.  
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3. RESULTS AND DISCUSSION 
Peptides obtained from phage or cell surface display libraries are generally short 
ones, composed of 7-14 amino acids. These kinds of short peptides can have many 
conformations but, on the other hand, this can result in the reduction of the 
conformation of its active forms. Multimerization of the short peptide sequences 
could change their properties by making a more rigid structure, which might be 
especially important in the controlled assembly. An increase in the number of 
binding sites in repeating polypeptides might provide an improvement in binding 
affinity or specificity. The optimal conformation for the surface recognition or 
desired characteristics of the peptide could be obtained by modifying the repeating 
forms, as a way of multimerization [16]. 
In this study, we have studied two inorganic binding peptides; GBP1 & QBP1. 
Quartz Binding Peptide 1 was previously identified by bioinformatics tools from a 
large group of strong quartz binders selected by phage display in M13. Gold Binding 
Peptide was previously identified by cell surface display in E. coli. The second-
generation peptides, used in these studies were genetically designed as multiple 
repeats (three) in both of the inorganic binders. Both of the peptide sequences were 
amplified and cloned into an expression vector by linking them with a peptide linker. 
The bi-functional peptide was expressed, purified and the functionalities of the both 
domains have been investigated. 
3.1. Construction of the Bi-functional Peptide Vector 
3.1.1. Cloning of 3RQBP1 Sequence into pQE-2 Expression Vector 
For the construction of the bi-functional peptide vector, first, the cloning of the 
3RQBP1 was accomplished. For this, this sequence was amplified by using PCR. 
The synthesized oligonucleotide, which is 140 base in length, was used as the 
template. This oligonucleotide has a content of QBP1 sequence as three repeats, two 
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stop codons (TAATAA) at the end of the 3rd repeat of the QBP1 sequence and PstI 
and Acc65I restriction sites at each end. The sequence of the oligonucleotide with 
primer binding sites and the restriction sites yielding 3RQBP1 DNA are given in 
Figure 3.1.  
 
    5`-GGATCAGGTACCCCTCCTCCTTG-3` 
  5`-GGATCAGGTACCCCTCCTCCTTGGTTGCCTTATATGCCTCCTTGGTCT 
       Acc65I 
 
    CCTCCTCCTTGGTTGCCTTATATGCCTCCTTGGTCT 
 
           STOP   PstI 
    CCTCCTCCTTGGTTGCCTTATATGCCTCCTTGGTCTTAATAACTGCAGACTAC-3`
          3`-AGGAACCAGAATTATTGACGTCTGATG-5` 
 
Figure 3.1: The sequence of the 3RQBP1 oligonucleotide. Primer binding sites are 
shown in blue. Multiple units of 3RQBP1 are shown in red, each repeat in one row. 
The restriction sites are shown as underlined in different colors; Acc65I in green and 
PstI in purple. Stop codons at the end of the peptide coding sequence are shown in 
bold. 
In the designing of the oligonucleotide, the sequence of the quartz binder region was 
used as three tandem repeats. Stop codons were placed to the end of the region and 
the restriction sites introduced to the sequence was selected by regarding some 
issues. The strategy for the construction of the bifunctional peptide was developed to 
ligate two domains separately. For this ligation, three different restriction sites given 
in the multiple cloning site of the pQE-2 vector was chosen (Figure pQE-2). PstI and 
Acc65I was selected for the quartz binder. Here, the reason for choosing Acc65I site 
was because of its protein coding sequence. Acc65I nucleotide recognition site is 
GGTACC which is expressed as Glycine and Threonine (GT) respectively. As it was 
mentioned before, the peptide sequence to be used for linking two GEPIs were 
chosen as GGGGSGGGGT. By selecting Acc65I as the restriction site, two residues 
of the linker region were already cloned into the expression vector. The remaining 
eight residues of the linker was added to the end of the gold binder region by PCR 
(will be discussed later).  
The forward and the reverse primers were used for the amplification of the sequence 
and at the end of the reaction a double stranded 3RQBP1 DNA sequence with 
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restriction sites was obtained from a single stranded oligonucleotide. The result of 
the PCR is analyzed by agarose gel electrophoresis (Figure 3.2)      
 
                                          
Figure 3. 2: 2.5% agarose gel. Lane 1: Marker 10, PhiX174 DNA/HinfI Marker, 
Lane 2: PCR product obtained from Tm = 55°C reaction, Lane 3: PCR product 
obtained from Tm = 58°C reaction, Lane 4: PCR product obtained from Tm = 60°C 
reaction. 
After verification of obtaining the desired DNA fragment by agarose gel 
electrophoresis, the DNA fragments were extracted from the gel and were cloned 
into pDrive cloning vector and transformed into E.coli competent cells. Top10 E. coli 
electrocompetent cells were used for transformation. pDrive is a TA cloning vector 
that needs unpaired Adenine residues on 3'-ends of the DNA fragment to be inserted. 
Although, Taq DNA polymerase adds Adenine residues to 3'-ends of amplified DNA 
sequence with a longer final extension step during PCR, an extra A-Addition step 
was performed to be sure that unpaired Adenine residues were added to 3'-ends of 
the amplified 3RQBP1 sequence. By cloning our PCR product into pDrive cloning 
vector, it was easily checked by DNA sequencing if there was any mutation in our 
sequence and 20 positive colonies were then grown to have the required amount of 
insert DNA for ligation into expression vector.  
pDrive vector DNA with 3RQBP1 insert was amplified, purified and digested with 
PstI and Acc65I restriction enzymes. Three DNA fragments, which are 126 bp, 54 bp 
140 bp 
200 bp 
   1    2  3        4 
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and 3603 bp in length, were obtained after digestion. Digestion mixture was run on 
2.5% agarose gel and desired 126 bp fragment which belongs to 3RQBP1 was gel 
extracted (Figure 3.3.)  
      A.                    B.  
                      
  
 
 
 
 
 
  
 
 Figure 3.3: A. 2.5% agarose gel; Lane 1: DNA fragments obtained after PstI and 
Acc65I digestion of pDrive having 3RQBP1, Lane 2: Marker 10, PhiX174 
DNA/HinfI Marker B. 2.5% agarose gel; Lane 1: Marker 10, PhiX174 DNA/HinfI 
Marker, Lane 2: 3RQBP1 after gel extraction.  
 
 
 
 
 
 
 
 
 
Figure 3.4: 1% agarose gel; Lane 1: Marker 3, Lambda DNA / EcoRI+HindIII, Lane 
2: linear pQE-2 vector obtained after PstI and Acc65I digestion.   
118 bp 
140 bp 
    1      2 
  1                2 
  1     2 
21226 bp 
5148 bp 
4268 bp 
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Following the extraction of the digestion products which had the same sticky ends, 
the 3RQBP1 DNA fragment (Figure 3.3) was ligated into the pQE-2 vector (Figure 
3.4). The ligation product was transformed into Top10 chemically competent cells. 
White colonies on LB Agar + Ampicillin plates were selected, grown in LB broth 
medium and plasmid DNA of the bacteria was purified to check their sequence. After 
confirming with the DNA sequencing results, construction of the pQE-2 vector with 
3RQBP1 insert was accomplished. 
3.1.2. Cloning of 3RGBP1 + Linker Sequence into pQE-2 Expression Vector 
For the construction of the bi-functional peptide vector, cloning of the 
3RGBP1+Linker sequence was done later. For this insertion, 3RGBP1 sequence was 
amplified by using PCR. p53Q vector, which contains a three-repeat GBP1 sequence 
was used as the template. Forward and reverse primers were used for the introduction 
of the restriction sites Acc65I and EagI and also a linker sequence composed of 30 
bases (10 amino acids; GGGGSGGGGT). The sequence of the primer binding sites 
and the restriction sites yielding 3RGBP1+Linker DNA are given in Figure 3.5.  
 
     NotI    Q    
5’-GCGGCCGCGCAAATGCATGGAAAAACTCAGGCA-3’ 
           5’-ATGCATGGAAAAACTCAGGCAACCAGCGGGACTATCCAGAGC 
 
ATGCATGGAAAAACTCAGGCAACCAGCGGGACTATCCAGAGC 
 
ATGCATGGAAAAACTCAGGCAACCAGCGGGACTATCCAGAGC-3’ 
                    3’-GTCGCCCTGATAGGTCTCGCCACCTCCACCATCGCCGCCACCTCCATGG-5’ 
                                                                  Acc65I 
 
Figure 3.5: Amplification of the 3RGBP1 sequence by adding linker region to its 
end. Primer binding sites are shown in blue. Multiple units of 3RGBP1 are shown in 
bold, repeat in one row. The restriction sites are shown as underlined in different 
colors; Acc65I in green and NotI in gray. 
The result of the PCR is analyzed by agarose gel electrophoresis (Figure 3.6).  
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Figure 3. 6: 2.5% agarose gel. Lane 1: Marker 10, PhiX174 DNA/HinfI Marker, 
Lane 2: PCR product obtained from Tm = 50°C reaction 
After confirmation of obtaining the desired DNA fragment by agarose gel 
electrophoresis, the DNA fragments were extracted from the gel and were cloned 
into pCR 2.1-TOPO cloning vector and transformed into E.coli competent cells. 
Top10 E. coli chemically competent cells were used for transformation. pCR 2.1-
TOPO is, like pDrive, a TA cloning vector, that needs unpaired Adenine residues on 
3'-ends of the DNA fragment to be inserted. But, the amplification was done by using 
Pfu DNA polymerase, which has a 3'→5' exonuclease (proofreading) activity. So, 
unlike Taq DNA polymerase, no Adenine residues were added to 3'-ends of 
amplified DNA sequence even with a longer final extension step during PCR. Thus, 
an A-Addition step was performed to have Adenine residues added to 3'-ends of the 
amplified 3RGBP1 + Linker sequence. By cloning our PCR product into pCR 2.1-
TOPO cloning vector, it was easily checked by DNA sequencing if there was any 
mutation in our sequence and 24 positive colonies were then grown to have the 
required amount of insert DNA for ligation into expression vector.  
pCR 2.1-TOPO vector DNA with 3RGBP1 + Linker insert was amplified, purified 
and digested with Acc65I and EagI restriction enzymes. Three DNA fragments, 
which are 168 bp, 3813 bp and 3843 bp in length, were obtained after digestion. 
Digestion mixture was run on 2.5% agarose gel and desired 168 bp fragment which 
belongs to 3RGBP1 + Linker sequence was extracted from the gel (Figure 3.7). 
 
200 bp 
151 bp 
        1                2 
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      A.                        B.  
 
 
 
 
 
 
Figure 3.7: A. 2.5% agarose gel; Lane 1: Marker 10, PhiX174 DNA/HinfI Marker, 
Lane 2: DNA fragments obtained after Acc65I and EagI digestion of pCR 2.1-TOPO 
containing 3RGBP1 + Linker sequence B. 2.5% agarose gel; Lane 1: 3RGBP1 + 
Linker after gel extraction, Lane 2: Marker 10, PhiX174 DNA/HinfI Marker 
 
 
 
 
Figure 3. 8: 1% agarose gel; Lane 1: linear pQE-2 + 3RQBP1 vector obtained after 
Acc65I and EagI digestion, Lane 2: Marker 3, Lambda DNA / EcoRI+HindIII 
 
     1         2 
    1    2 
200 bp 
151 bp 
  1         2 
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Following the extraction of the digestion products which had the same sticky ends, 
the 3RGBP1 + Linker DNA fragment (Figure 3.7) was ligated into the pQE-2 + 
3RQBP1 vector (Figure 3.8). The ligation product was transformed into Top10 
chemically competent cells. White colonies on LB Agar + Ampicillin plates were 
selected, grown in LB broth medium and plasmid DNA of the bacteria was purified 
to check their sequence. After verifying with the DNA sequencing results, 
construction of the pQE-2 vector with the bi-functional peptide insert was 
accomplished.  
3.2. Expression and Purification of the Bi-Functional Peptide 
After verifying the construction of the bi-functional peptide with the sequencing 
results, expression studies were performed. For this, some pilot experiments were 
done to get the optimum parameters for expression and purification.  
The expression vector used in this study is pQE-2 from Qiagen, which are used for 
expressing N-terminally Histidine tagged proteins in E. coli. Expression of the 
recombinant proteins encoded by pQE-2 vector is rapidly induced by the addition of 
isopropyl-β-D-thiogalactoside (IPTG) which binds to the lac repressor protein and 
inactivates it. Just the once the lac repressor is inactivated, the sequences 
downstream from the promoter region can be transcribed by the RNA polymerase of 
the host cell. These transcripts are later translated into the recombinant protein [32]. 
Once this recombinant protein is expressed by the host cell, it will have an affinity 
tag in its N-terminus composed of 6 Histidine residues. By the help of this tag, 
expressed recombinant protein can be purified from the culture medium by Affinity 
Chromatography. The system used in this study is based on the selectivity and the 
affinity of nickel-nitrilotriacetic acid (Ni-NTA) metal affinity chromatography 
matrices for the 6xHistidine tagged proteins. Ni-NTA is a tetradentate chelating 
adsorbent in which Nitrilotriacetic Acid keeps four over six free sites of nickel ion, 
thus, causing two sites free for the interaction with the Histidine tag (See 
Introduction, Figure 1.3). The structure of the Histidine amino acid is composed of 
an imidazole ring as the radical group. This imidazole ring is responsible for the 
binding of the Histidine tag to the nickel ions that are immobilized by the NTA 
groups of the matrix. Imidazole can also bind to the nickel ions by itself, so, it is 
found in the purification buffers at different concentrations. Non-specific binding of 
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the background proteins in the culture is avoided at low imidazole concentrations 
while 6xHistidine-tagged proteins still bind to the matrix strongly. Hence, low 
concentrations of imidazole are used in the lysis and wash buffers (10-20 mM) [28].  
The Histidine-tagged protein bound to the Ni-NTA matrix can be eluted by 
increasing the imidazole concentration to 100-250 mM because they can not compete 
with this high concentration of imidazole and dissociate from the matrix.  
In to pilot experiments, the optimum parameters for the expression of the peptide 
were obtained. The optimum growth temperature for our peptide is always 37 ºC. 
The IPTG induction is done when the peptides grow to an OD600 of 0.5 and the final 
concentration of IPTG is 1 mM. Following induction, the optimum time for the 
production of our peptide in culture medium is 5 hours. After 5 hours of growth, the 
culture was spin down and the pellets containing the cells were used for the 
purification of the bi-functional peptide (Figure 3.9).  
 
    
Figure 3.9: %8-20 SDS-PAGE result. Lane 1: Uninduced culture grown for 2 hours, 
Lane 2: Uninduced culture grown for 3 hours, Lane 3: Uninduced culture grown for 
4 hours, Lane 4: Uninduced culture grown for 5 hours, Lane M: BenchMark™ Pre-
Stained Protein Ladder, Lane 5: Induced culture grown for 2 hours, Lane 6: Induced 
culture grown for 3 hours, Lane 7: Induced culture grown for 4 hours, Lane 8: 
Induced culture grown for 5 hours 
 
14.8 kDa 
 
6 kDa 
          1        2         3         4      M        5         6        7        8   
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In the purification procedure, three different steps were performed for the complete 
lysis of the cells. First, the cells were resuspended in lysis buffer (which contains 10 
mM imidazole). Following resuspension, lysozyme was added to the resuspension 
and was incubated on ice for 30 minutes. Lyszozyme (EC 3.2.1.17, 129 amino acids, 
14,7 kDa) is an enzyme that is extracted from the egg white and acts by damaging 
the cell walls of the bacteria by hydrolysis of 1,4-beta-linkages between N-
acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and 
between N-acetyl-D-glucosamine residues in chitodextrins [51]. Following enzyme 
treatment, the cells were sonicated on ice. In this step, the cell membranes are totally 
disrupted and cellular contents are released.  
After lysis of the cells, all the content of the cells are treated with Ni-NTA resin. In 
this step, our Histidine-tagged peptide is bound to the resin while all the other 
peptides are not. After washing with wash buffer (which contains 20-50 mM 
imidazole), other possible non-specific bindings are also removed from the resin. 
Finally, our peptide is eluted by washing the resin with elution buffer (which 
contains 250 mM imidazole). Obtained samples were analyzed by using SDS-PAGE 
(8-20%). Our peptide (11,5 kDa) was purified and can be seen elution fragments. In 
the flow through samples all the unbound peptides, especially lysozyme, is seen and 
non-specific bindings removed by washing steps is seen in the wash samples (Figure 
3.10). 
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Figure 3.10: %8-20 SDS-PAGE result. Lane 1: Fraction obtained from the first 
washing step, Lane 2: Cleared lysate, Lane 3: Unstained Protein Molecular Weight 
Marker, Lane 4: Fraction obtained from the first elution step, Lane 5: Fraction 
obtained from the second elution step, Lane 6: Fraction obtained from the third 
elution step, Lane 7: Fraction obtained from the fourth elution step, Lane 8: Empty, 
Lane 9: BenchMark™ Pre-Stained Protein Ladder, Lane 10: Flow through fraction 
 
 
 
 
14,4 kDa 
11,5 kDa 
6 kDa 
        1       2        3        4       5         6        7        8        9       10   
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4. CONCLUSION 
A fusion peptide consisting of a quartz binding peptide and a gold binding peptide, 
which are previously well-characterized inorganic binding domains, was constructed 
by using genetic engineering methods and the protein was expressed and purified via 
Nickel-Nitrilotriacetic Acid Immobilized Metal Affinity Chromatography.  
GBP1 is a 14-mer peptide selected from a peptide library expressed on the outer 
surface of Escherichia coli with an amino acid sequence of MHGKTQATSGTIQS. 
QBP1 is a 12-mer peptide, which were de novo designed peptides by in silico 
selection of strong-binding QBPs by using bioinformatics tools. Both the Gold 
binding peptide and the Quartz binding peptide were used as three tandem repeats 
with the idea that repeated structures the sequences could show a better affinity and 
provide an enhancement in binding strength by increasing the surface recognition 
sites. The peptides were linked to each other by a ten-amino acid flexible peptide 
linker rich in Glycine content with a sequence of GGGGSGGGGT. 
In developing the construction and expression of this peptide, we utilized the 
molecular biology tools like polymerase chain reaction and immobilized metal 
affinity chromatography, which are widely-used techniques in vector construction 
and protein purification. 
Our experiments indicated that enabling technologies could be developed for in vivo 
production of peptides at desired amounts with multi-activities and selected bi-
functional peptide will be utilized in nanoparticle and surface assemblies in 
bio/nanotechnologies. 
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APPENDIX 
Appendix A. 
Vector Map of pDrive 
Position (bp)  Element 
266–393  Multiple cloning site  
216–593  LacZ α-peptide  
239–258  T7 RNA polymerase promoter  
start 256  T7 transcription  
398–417  SP6 RNA polymerase promoter  
start 400  SP6 transcription  
1175–2032  Ampicillin resistance gene  
2181–2993  Kanamycin resistance gene  
3668   pUC origin  
588–1043  Phage f1 origin  
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Appendix B. 
 
Vector Map of pCR 2.1 
 
 
 
Position (bp)  Element 
1–547   LacZα fragment  
205–221  M13 reverse priming site  
234–357  Multiple cloning site  
364–383  T7 promoter/priming site  
391–406  M13 Forward (-20) priming site 
548–985  f1 origin  
1319–2113  Kanamycin resistance ORF 
2131–2991  Ampicillin resistance ORF 
3136-3809  pUC origin  
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Appendix C. 
 
Molecular Weight Markers 
 
              a)           b)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a)  λDNA EcoRI and HindIII digested marker-3, 1.0% agarose, 0.5µg/lane, 8 cm 
length  gel, 1X TAE, 17V/cm. (Catalog # SM0191, NBI Fermentas). 
b)  ΦX174 DNA HinfI digested marker-10, 2.5% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0261, NBI Fermentas). 
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Appendix D. 
Lab Equipments 
Autoclaves     : 2540 ML benchtop autoclave, Systec GmbH 
Labor-Systemtechnik. 
: NuveOT 4060 vertical steam sterilizer, Nuve. 
Centrifuges     : Avanti J-30I, Beckman Coulter. 
: Microfuge 18, Beckman Coulter. 
Centrifuge rotors    : JA30.50Ti, Beckman Coulter. 
: F241.5P, Beckman Coulter. 
Deep freezes and refrigerators  : Heto Polar Bear 4410 ultra freezer, JOUAN 
Nordic A/S, catalog# 003431. 
: 2021 D deep freezer, Arcelik. 
: 1061 M refrigerator, Arcelik. 
Electrophoresis equipments  : E-C Mini Cell Primo EC320, E-C Apparatus. 
: Mini-PROTEAN 3 Cell and Single-Row 
AnyGel Stand, Catalog# 165-3321,Bio-Rad. 
: Mini-V 8.10 Vertical Gel Electrophoresis 
System, Life Technologies GibcoBrl (now 
Invitrogen), Catalog# 21078. 
Gel documentation system   : UVIpro GAS7000, UVItec Limited. 
Ice Machine     : AF 10, Scotsman. 
Incubators     : EN400, Nuve. 
Orbital shaker    : Certomat S II, product# 886 252 4, B. Braun 
Biotech International GmbH. 
Magnetic stirrer    : AGE 10.0164, VELP Scientifica srl. 
: ARE 10.0162, VELP Scientifica srl. 
Pipettes     : Pipetteman P10, Eppendorf 
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pH meter     : MP 220, Mettler Toledo International Inc. 
: Inolab pH level 1, order# 1A10-1113, 
Wissenschaftlich-Technische Werkstätten 
GmbH & Co KG. 
Power supply    : EC 250-90, E-C Apparatus. 
Pure water systems    : USF Elga UHQ-PS-MK3, Elga Labwater. 
Spectrophotometer    : DU530 Life Science UV/ Vis, Beckman. 
: UV-1601, Shimadzu Corporation. 
Sterilizer     : FN 500, Nuve. 
Transilluminator    : UV Transilluminator 2000, Catalog# 170- 
8110EDU, Bio- Rad. 
Vortexing machine    : Reax Top, product# 541-10000, Heidolph2.2. 
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